Strict management of secondary hyperparathyroidism may be necessary to improve prognosis in patients on dialysis who have coronary artery disease requiring percutaneous coronary intervention.
Serum levels of phosphate and parathyroid hormone are lower early in the day and higher late in the day, recently reported data suggest.
The hospitalization rate and number of hospital days increased significantly in the year after parathyroidectomy vs the year before, whereas dialysis visits and office visits decreased significantly.
In a retrospective study, investigators found that radiofrequency ablation and parathyroidectomy for secondary hyperparathyroidism in patients on dialysis achieved intact parathyroid hormone levels in the target range in similar proportions of patients.
Finerenone reduced the incidence of the primary composite endpoint of CV death, nonfatal MI, nonfatal stroke or hospitalization for heart failure by 13%.
The FDA has approved Kyzatrex (testosterone undecanoate) for the treatment of primary and secondary hypogonadism in adult males.
The EMPRISE study assessed the efficacy and safety of empagliflozin use in approximately 500,000 adults with type 2 diabetes.
Recent findings suggest that impaired kidney function may better reflect anorexia severity.
The study authors conducted a nationwide cohort study that included 137,667 Medicare beneficiaries.
